Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 35.14B | 25.26B | 24.08B | 53.99B | 25.72B | 18.83B |
Gross Profit | 35.56B | 52.51B | 24.08B | 25.51B | 25.72B | 18.83B |
EBITDA | 8.35B | 0.00 | 12.84B | 9.58B | 13.48B | 0.00 |
Net Income | 5.47B | 4.20B | 2.49B | 1.82B | 5.64B | -258.00M |
Balance Sheet | ||||||
Total Assets | 1.55T | 1.57T | 1.55T | 1.49T | 1.46T | 1.46T |
Cash, Cash Equivalents and Short-Term Investments | 212.56B | 317.62B | 327.40B | 289.83B | 284.55B | 245.79B |
Total Debt | 172.72B | 112.62B | 179.81B | 89.00B | 41.76B | 83.84B |
Total Liabilities | 1.47T | 1.49T | 1.48T | 1.41T | 1.39T | 1.38T |
Stockholders Equity | 68.29B | 70.26B | 65.97B | 66.97B | 65.07B | 61.68B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -21.53B | 25.56B | 29.50B | 13.83B | 75.20B |
Operating Cash Flow | 0.00 | -10.10B | 37.42B | 39.09B | 20.29B | 80.79B |
Investing Cash Flow | 0.00 | -13.74B | -12.07B | -9.01B | -10.12B | -6.86B |
Financing Cash Flow | 0.00 | -1.27B | -3.90B | -214.00M | -3.63B | 2.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $70.24B | 11.51 | 11.31% | 3.68% | 1.94% | 30.93% | |
77 Outperform | $44.87B | 9.62 | 7.25% | 1.16% | -13.59% | 182.59% | |
73 Outperform | $20.84B | 10.88 | 11.43% | 4.30% | 4.28% | 28.54% | |
73 Outperform | $69.66B | 9.72 | 20.49% | 6.26% | 5.44% | 2.81% | |
70 Neutral | $67.01B | 12.98 | 10.06% | 3.78% | 0.76% | -5.74% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $78.54B | 13.29 | 8.69% | 1.53% | -2.22% | 24.37% |